MedTrace Logo

Study of Time-restricted Eating (TRE) to Clinical Pregnancy Rate in PCOS Women With Glucose Metabolism Disorder Via IVF/ICSI

NCT06666933 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 254

Last updated 2024-10-31

No results posted yet for this study

Summary

Investigate the effect and mechanism of time-restricted eating (TRE) on the clinical pregnancy rate in women with PCOS and glucose metabolism disorder via IVF/ ICSI.

Conditions

  • PCOS
  • Glucose Metabolism Disorder
  • IVF Outcome

Interventions

BEHAVIORAL

Time restricted eating

TRE (eating is allowed from 8am to 4pm without limitation in calories) with metformin 1g bid po for 6 weeks

DRUG

Metformin

Taking metformin 1g bid po only for 6 weeks as control

Sponsors & Collaborators

  • Guangdong Provincial People's Hospital

    collaborator OTHER

  • Shanghai First Maternity and Infant Hospital

    collaborator OTHER

  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER

  • Shengjing Hospital

    collaborator OTHER

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Tao Tao, MD · RenJi Hospital Department of Endocrinology and Metabolism

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-11-30
Completion
2026-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06666933 on ClinicalTrials.gov